Opus Investment Management Inc. lifted its holdings in shares of CVS Health Corp (NYSE:CVS) by 79.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 48,900 shares of the pharmacy operator’s stock after purchasing an additional 21,700 shares during the quarter. Opus Investment Management Inc.’s holdings in CVS Health were worth $3,147,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in CVS. Adviser Investments LLC grew its position in CVS Health by 43.3% in the 2nd quarter. Adviser Investments LLC now owns 2,993 shares of the pharmacy operator’s stock worth $193,000 after purchasing an additional 905 shares during the last quarter. Keystone Financial Planning Inc. grew its position in CVS Health by 44.5% in the 2nd quarter. Keystone Financial Planning Inc. now owns 59,038 shares of the pharmacy operator’s stock worth $3,799,000 after purchasing an additional 18,176 shares during the last quarter. ICM Asset Management Inc. WA acquired a new stake in CVS Health in the 2nd quarter worth $1,152,000. Girard Partners LTD. grew its position in CVS Health by 9.7% in the 2nd quarter. Girard Partners LTD. now owns 40,366 shares of the pharmacy operator’s stock worth $2,598,000 after purchasing an additional 3,582 shares during the last quarter. Finally, Dynamic Advisor Solutions LLC grew its position in CVS Health by 12.6% in the 2nd quarter. Dynamic Advisor Solutions LLC now owns 31,538 shares of the pharmacy operator’s stock worth $2,029,000 after purchasing an additional 3,518 shares during the last quarter. Institutional investors own 83.56% of the company’s stock.

In other news, EVP Kevin Hourican sold 8,564 shares of the firm’s stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $75.00, for a total transaction of $642,300.00. Following the completion of the transaction, the executive vice president now directly owns 12,135 shares of the company’s stock, valued at approximately $910,125. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.53% of the stock is currently owned by company insiders.

CVS has been the topic of several research analyst reports. Loop Capital set a $68.00 price target on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, May 7th. Mizuho set a $95.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, June 13th. ValuEngine upgraded shares of CVS Health from a “strong sell” rating to a “sell” rating in a research report on Tuesday. Royal Bank of Canada decreased their price target on shares of CVS Health to $84.00 and set an “outperform” rating on the stock in a research report on Friday, June 29th. Finally, Citigroup restated a “buy” rating and issued a $81.00 price target on shares of CVS Health in a research report on Monday, July 9th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $86.04.

NYSE:CVS opened at $74.53 on Friday. The stock has a market cap of $76.27 billion, a PE ratio of 12.63, a price-to-earnings-growth ratio of 1.01 and a beta of 0.96. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $84.00. The company has a quick ratio of 1.87, a current ratio of 2.34 and a debt-to-equity ratio of 1.73.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 EPS for the quarter, topping analysts’ consensus estimates of $1.61 by $0.08. The company had revenue of $46.71 billion during the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period last year, the firm earned $1.33 EPS. equities research analysts expect that CVS Health Corp will post 7.05 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.68%. The ex-dividend date of this dividend was Tuesday, July 24th. CVS Health’s payout ratio is 33.90%.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Read More: Trading Strategy

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.